MedPath

Study to compare Bupivacaine heavy, Levobupivacaine plain and Levobupivacaine heavy with Fentanyl (opioid) as an add on drug under spinal anesthesia in Prostate surgery.

Phase 4
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2023/06/054367
Lead Sponsor
Dr Sanyukta Paul
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient giving consent to participate in study

Age between 50-75 years

Weight between 45-70 kg

ASA grade I and II

Patient scheduled for TURP surgeries.

Exclusion Criteria

Patients not giving consent to participate in the study.

Uncooperative patient

ASA grade III and IV

Patients with respiratory, cardiovascular, renal diseases, obesity.

Neurological disease (multiple sclerosis, symptomatic lumbar herniated disc, spinal stenosis)

Coagulopathy

Patient with known hypersensitivity to local anaesthetic.

Local sepsis or infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected prolonged efficacy of Levobupivacaine 0.5% heavy over Bupivacaine 0.5% heavy & Levobupivacaine 0.5% plainTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
Expected lesser side effects & stable hemodynamic profile with Levobupivacaine 0.5% heavy than Bupivacaine 0.5% heavy and Levobupivacaine 0.5% plainTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath